Skip to main content

This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A

Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.